INTRODUCTION
Toxoplasma gondii is an obligate intracellular protozoan parasite that belongs to the phylum Apicomplexa, subclass coccidia. T. gondii has two parts in lifecycle. While the sexual part of the lifecycle occurs in domestic and wild cats, asexual part occurs in any mammal. Human beings can be infected with T. gondii by ingestion or handling of undercooked or raw meat containing tissue cysts, drinking water contaminated with oocysts from feline feces, transplantation of infected organs or ingestion of oocysts through close contact with infected cat or feline feces 1 .
Most individuals are infected inadvertently, thus the specific route of transmission cannot usually be established. Variations in seroprevalence of T. gondii seem to correlate with eating and hygiene habits of a population. This finding lends support to the contention that the oral route is the major source of infection 2 .
It's known that approximately 1/3 of the world population is infected by T. gondii. Clinically, infection can go unnoticed or could cause signs and symptoms that vary depending on the immune status of the patient and the clinical setting like ocular disease or congenital toxoplasmosis [3] [4] . As an effective vaccine has not yet been developed, continuous and detailed epidemiological surveillance is required to estimate the risk of infection, especially in pregnant women, and the likelihood of reactivation in immunocompromised individuals 5 .
MATERIAL AND METHODS
In this study, seropositivity of antibodies against toxoplasma in patients with suspected toxoplasmosis was retrospectively evaluated in Medical Microbiology Laboratory of Selcuk University Medical Faculty between January 2013 and December 2016. Blood samples of patients were centrifuged at 4.500 rpm for 15 minutes. Then serum fraction of blood samples was extracted. Anti-T. gondii immunoglobulin M (IgM), immunoglobulin G (IgG) antibodies and IgG avidity were studied in 7051 serum samples by using the VIDAS (BioMérieux, France) kits and the Enzyme Linked Fluorescence Assay technique. For IgG, >8 UI/ml test value and for IgM, >0.65 index test value were accepted positive. >0.3 avidity index was interpreted as high.
RESULTS
In all 7051 patients, seropositivity rates of anti-T. gondii IgM and IgG antibodies were 2.44 and 29.53%, respectively. At Table 1 , there are all rates of anti-T. gondii IgM and IgG antibodies. Seropositivity rates of toxoplasma IgM antibodies in female and male patients were 2.80 and 1.14%, respectively. IgG seropositivity rates in female and male patients were 34.17 and 22.91%, respectively.
Seropositivity rate of anti-T. gondii IgM antibodies in women at fertility ages was shown at Table 2 . The rate of anti-T. gondii IgM positivity was 2.92% in 3249 women of fertile age.
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DISCUSSION
The seropositivity of toxoplasmosis varies in many countries and even in different regions within a country, depending on the differences in socioeconomic situation, development levels, climate, and geography, which has been reported to range between 12-90%. The IgG seropositivity was reported to be 37%, 29%, and 24% in 1984, 1997, and 2004, respectively in Greece, which is in the same climate zone as Turkey 6 . Researchers have related this decreasing trend to socioeconomic development.
IgG and IgM seropositivity has been reported as 23.3-37.1% and 0.1-1.9% in patients prediagnosed with toxoplasmosis in Turkey 7, 8, 9 . This difference may be attributed to the size of the working groups, socio-demographic characteristics, and habits, as well as the climatic characteristics and test sensitivity. In this study, seropositivity of IgG was higher than of IgM. IgG and IgM seropositivity were found to be 29.53 and 2.44 %, respectively. In our region, these seropositivity rates show similarity with seropositivity rates of the other studies in Turkey. This contribute that T. gondii IgG antibodies are reflection of past or previous infection, while IgM reflects recent or acute T. gondii infection.
Many studies have investigated the relationship between T. gondii seropositivity and gender both in Turkey and in the world. In a study conducted in Brazil, IgG seropositivity was found to be 63.4% in women and 79% in men 10 . In a study from United States, the seropositivity was found to be 23.3% and 21.8% in women and men, respectively 11 . In our study, seropositivity rates of toxoplasma IgM and IgG antibodies were 2.80 and 34.17% in women and 1.14 and 22.91% in men, respectively. This may be attributed to the fact that as opposed to men, women contact contaminated raw food and are at a higher risk of exposure to oocysts disseminated by cats during household chores and gardening work.
The IgG avidity tests that have been in practical use in recent years allow reliable differentiation between acute primary infection, reactivation, and/ or re-infection in a single serum sample. This differentiation has clinical significance, especially in pregnant women and immunocompromised patients. IgG antibodies against the antigen on first exposure during the primary infection show low avidity in the first weeks and then acquire gradually higher avidity with increased maturity. Alver at al. 12 found the high avidity in 136 (81.9%), borderline in 17 (10.2%), and low in 13 (7.9%) patients in their study. In our study we found the high avidity in 134 (78.36%), borderline in 10 (6.15%), and low in 27 (15.39%) of 171 samples. In our study, 60 patients (35.08%) had IgM positivity, of whom 13 (21.66%) had low avidity, suggesting a recent previous infection, while 40 (66.66%) had high avidity, suggesting a past or previous infection. Avidity of seven patients who had IgM positivity was borderline (11.66%). Also 111 patients (64.92%) had IgM negativity. 94 (70.15%) of them had high avidity.
In pregnant women, multiparity, older age, and a history of poor obstetric outcome have been previously described as risk factors for T. gondii infections [13] [14] . In a study conducted in Turkey, seroprevalence of T. gondii IgM were determined among women of childbearing age (15-49 ages) . Positive rate of the T. gondii IgM antibodies was found as 4.6 %. In our study, Ig M rate was found lower as 2.92% 15 . Enter at al. 16 found Toxoplasma gondii Ig M rate as 1.5% seropositivity among pregnant women.
CONCLUSION
Toxoplasma gondii is able to infect all warmblooded animals and chronically infects approximately one-third of the world's human population . T. gondii can cause serious clinical consequences and even death in immunocompromised individuals or patients undergoing immunosuppressive treatments or during pregnancy 17 . Regular surveillance studies on toxoplasmosis seroprevalence must continue in our country in order to prediction of congenital toxoplasmosis risk, determination of screening strategies and important for informing the seronegative pregnancies on the prevention methods.
